keepbuying Posted - 11 hours ago

$NXTC https://finance.yahoo.com/news/nextcure-present-phase-1b-data-200500777.html

Stock_Titan Posted - 11 hours ago

$NXTC NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024 https://www.stocktitan.net/news/NXTC/next-cure-to-present-phase-1b-data-of-nc410-in-combination-with-39j9a6nfwn4u.html

Ohyaythejoy Posted - 5 days ago

$NXTC fucking garbage.

Ohyaythejoy Posted - 1 week ago

$NXTC hunk of fucking dog shit just took back 9k out of my account t fuck nxtc yay!

keepbuying Posted - 1 week ago

$NXTC ADC…

nickd1234 Posted - 1 week ago

$NXTC again, pump n dump

Ohyaythejoy Posted - 1 week ago

$NXTC pure fucking trash....

Ohyaythejoy Posted - 1 week ago

$NXTC and we're still shit....

keepbuying Posted - 1 week ago

$NXTC speaking now at Needham https://ir.nextcure.com/investor-relations/

nickd1234 Posted - 2 weeks ago

$NXTC pump & dump

keepbuying Posted - 2 weeks ago

$NXTC ADC tech alone may be worth more than the whole mkt cap…..plus the cash!💰

DonCorleone77 Posted - 2 weeks ago

$NXTC 2 of 2 - NextCure and LCB present data on B7-H4 antibody drug conjugate at AACR ...."LNCB74 was developed through NextCure's expertise in B7-H4 tumor biology and LCB's ConjuAllTM technology, resulting in a potent ADC with initial data demonstrating excellent tolerability and pharmacokinetics," said Solomon Langermann, Ph.D., NextCure's chief scientific officer. "These data underscore that LNCB74 is a promising candidate for the treatment of a variety of solid tumor indications. We look forward to continuing our work building a robust preclinical dataset to further support advancing this ADC to the clinic."...LNCB74 was engineered for an improved safety profile and therapeutic index with increased stability in circulation, tumor selective payload release, and a reduction in off-target release of active payload, mitigating toxicity compared to traditional vedotin ADCs.

DonCorleone77 Posted - 2 weeks ago

$NXTC 1 of 2 - NextCure and LCB present data on B7-H4 antibody drug conjugate at AACR NextCure announced the presentation of new preclinical data on LNCB74, a B7-H4-targeting antibody drug conjugate ADC developed in partnership with LigaChem Biosciences LCB , formerly LegoChem Biosciences, , at the 2024 American Association for Cancer Research AACR Annual Meeting in San Diego, CA. The poster presentation highlights LNBC74's promising preclinical safety and anti-tumor activity. LNCB74 is an ADC utilizing LigaChem Biosciences' proprietary site-specific conjugation and plasma-stable, cancer selectively activating linker technology to link monomethyl auristatin E MMAE to a B7-H4 targeting antibody in a drug-to-antibody ratio of 4 DAR4 . The presentation includes data demonstrating LNCB74's high affinity and specificity for human B7-H4, a protein highly expressed on a range of solid tumors including breast, ovarian and endometrial cancers....

Stock_Titan Posted - 2 weeks ago

$NXTC NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024 https://www.stocktitan.net/news/NXTC/next-cure-and-lcb-present-preclinical-data-on-b7-h4-antibody-drug-abe4sqaebmwb.html

RallyRaider Posted - 2 weeks ago

$NXTC has tons of cash and is starting to go go long before data is due. Also has nice board additon and recent slides look promising. Wheres the catch?

Ohyaythejoy Posted - 2 weeks ago

$NXTC I'm still likely going to add again....

Ohyaythejoy Posted - 2 weeks ago

$NXTC creeping up.... I'm still dreaming of a lift off into space here..... maybe I'm delusional but 9000 shares keeps me dreaming....

keepbuying Posted - 2 weeks ago

$NXTC https://finance.yahoo.com/news/nextcure-appoints-dr-rakesh-dixit-110500996.html

keepbuying Posted - 2 weeks ago

$NXTC ADC expert just added to the team!

vaselineguy Posted - 3 weeks ago

$NXTC shiiiiiiix x another great call oh maaaaammmmaaa

Stock_Titan Posted - 3 weeks ago

$NXTC NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/NXTC/next-cure-to-present-at-23rd-annual-needham-virtual-healthcare-h7nxixw51fg1.html

_StockTrader Posted - 03/29/24

Real-Time Stock Data $NXTC Price: 2.27 Volume: 616283 Market Cap: 62223692 PE Ratio: -1.327381 Powered by: AITX

keepbuying Posted - 03/29/24

$NXTC

Nanu108 Posted - 03/28/24

$NXTC I'm out today at $2.2

Ohyaythejoy Posted - 03/28/24

$NXTC omg its still a pos.... let's hope we can get to double digits again.....

RollingDollar Posted - 03/28/24

$NXTC

vaselineguy Posted - 03/28/24

$NXTC I knew it. Big money coming here. Holding.

Biotech_Beast Posted - 03/27/24

$PYXS New article on the name here. An antibody and an ADC providing two shots on goal in H2'24. $NXTC https://seekingalpha.com/article/4680891-pyxis-oncology-data-arriving-later-than-expected-but-may-be-worth-the-wait

Ohyaythejoy Posted - 03/26/24

$NXTC gaining traction.....

Maggie2013 Posted - 4 weeks ago

$NXTC